Lutein-Containing Antioxidants in Patients with Primary Open-Angle Glaucoma and Dry Type of Age-Related Macular Degeneration
Objective. To assess the dynamics of structural-functional markers in patients with combined pathology: primary open-angle glaucoma (POAG) and age-related macular degeneration (AMD) with the background of lutein-containing drugs at long-term follow-up. Patients and Methods. The period of research wa...
Saved in:
Published in | Oftalmologii͡a Vol. 15; no. 3; pp. 339 - 347 |
---|---|
Main Author | |
Format | Journal Article |
Language | English Russian |
Published |
Ophthalmology Publishing Group
05.10.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective.
To assess the dynamics of structural-functional markers in patients with combined pathology: primary open-angle glaucoma (POAG) and age-related macular degeneration (AMD) with the background of lutein-containing drugs at long-term follow-up.
Patients and Methods.
The period of research was from November 2016 to January 2018; A parallel prospective study of patients (88 eyes), mean age 67.81 ± 8.41 (M ± σ); 67.64 (63.14; 73.08) (Me, Q25%, Q75%) years with combined pathology POAG and AMD (AREDS I and II). Patients were divided into 2 groups, the first group — a study group received Retinorm, by 1 capsule 3 times a day during a meal for 1 year, a second control group of 17 patients (32 eyes) did not receive lutein-containing medicines during the observation period. The study group consisted of 29 patients (55 eyes). There were 7 males and 22 females among them. The control group consisted of 19 patients (33 eyes), 2 males and 17 females among them. Visual acuity, standard automatic computer perimetry, optical coherence tomography, determination of spatial contrast sensitivity was carried out in all patients at the beginning of the study and after 1 year.
Results.
The maximum correlated visual acuity (MCVA) according to the table ETDRS increased in the study group and decreased in the control group, 95% the confidence interval for the changes in the MCVA: 0.1813636; 1.018182; 1.927273 и –3.878788; –2.393939; –0.8477273 (optotypes), respectively (W = 499.5; p = 0,0002919). Statistically significant changes in the thickness of the layer of nerve fibers of the retina (RNFL) neither in the middle nor in the sectors was revealed, and the thickness of the retina in oval foveal zone by sector: upper, temporal and lower statistically significantly decreased in the control group, while remaining unchanged in the observation group (р < 0.05). Spatial contrast sensitivity (SCS) after 1 year of use Retinorm remained at the same level in the control group, while there was a statistically significant increase in spatial contrast sensitivity in the main group, especially at high spatial frequencies is observed (р < 0.05).
Conclusion.
The results of the study indicate a positive effect of Retinorm used for 1 year. It was reflected in the improvement visual acuity in the distance, improvement of spatial contrast sensitivity, especially at high spatial frequencies, and the preservation of structural retinal indices both in the foveal zone and peripapillary. |
---|---|
AbstractList | Objective. To assess the dynamics of structural-functional markers in patients with combined pathology: primary open-angle glaucoma (POAG) and age-related macular degeneration (AMD) with the background of lutein-containing drugs at long-term follow-up. Patients and Methods. The period of research was from November 2016 to January 2018; A parallel prospective study of patients (88 eyes), mean age 67.81 ± 8.41 (M ± σ); 67.64 (63.14; 73.08) (Me, Q25%, Q75%) years with combined pathology POAG and AMD (AREDS I and II). Patients were divided into 2 groups, the first group — a study group received Retinorm, by 1 capsule 3 times a day during a meal for 1 year, a second control group of 17 patients (32 eyes) did not receive lutein-containing medicines during the observation period. The study group consisted of 29 patients (55 eyes). There were 7 males and 22 females among them. The control group consisted of 19 patients (33 eyes), 2 males and 17 females among them. Visual acuity, standard automatic computer perimetry, optical coherence tomography, determination of spatial contrast sensitivity was carried out in all patients at the beginning of the study and after 1 year. Results. The maximum correlated visual acuity (MCVA) according to the table ETDRS increased in the study group and decreased in the control group, 95% the confidence interval for the changes in the MCVA: 0.1813636; 1.018182; 1.927273 и –3.878788; –2.393939; –0.8477273 (optotypes), respectively (W = 499.5; p = 0,0002919). Statistically significant changes in the thickness of the layer of nerve fibers of the retina (RNFL) neither in the middle nor in the sectors was revealed, and the thickness of the retina in oval foveal zone by sector: upper, temporal and lower statistically significantly decreased in the control group, while remaining unchanged in the observation group (р < 0.05). Spatial contrast sensitivity (SCS) after 1 year of use Retinorm remained at the same level in the control group, while there was a statistically significant increase in spatial contrast sensitivity in the main group, especially at high spatial frequencies is observed (р < 0.05). Conclusion. The results of the study indicate a positive effect of Retinorm used for 1 year. It was reflected in the improvement visual acuity in the distance, improvement of spatial contrast sensitivity, especially at high spatial frequencies, and the preservation of structural retinal indices both in the foveal zone and peripapillary. Objective. To assess the dynamics of structural-functional markers in patients with combined pathology: primary open-angle glaucoma (POAG) and age-related macular degeneration (AMD) with the background of lutein-containing drugs at long-term follow-up. Patients and Methods. The period of research was from November 2016 to January 2018; A parallel prospective study of patients (88 eyes), mean age 67.81 ± 8.41 (M ± σ); 67.64 (63.14; 73.08) (Me, Q25%, Q75%) years with combined pathology POAG and AMD (AREDS I and II). Patients were divided into 2 groups, the first group — a study group received Retinorm, by 1 capsule 3 times a day during a meal for 1 year, a second control group of 17 patients (32 eyes) did not receive lutein-containing medicines during the observation period. The study group consisted of 29 patients (55 eyes). There were 7 males and 22 females among them. The control group consisted of 19 patients (33 eyes), 2 males and 17 females among them. Visual acuity, standard automatic computer perimetry, optical coherence tomography, determination of spatial contrast sensitivity was carried out in all patients at the beginning of the study and after 1 year. Results. The maximum correlated visual acuity (MCVA) according to the table ETDRS increased in the study group and decreased in the control group, 95% the confidence interval for the changes in the MCVA: 0.1813636; 1.018182; 1.927273 и –3.878788; –2.393939; –0.8477273 (optotypes), respectively (W = 499.5; p = 0,0002919). Statistically significant changes in the thickness of the layer of nerve fibers of the retina (RNFL) neither in the middle nor in the sectors was revealed, and the thickness of the retina in oval foveal zone by sector: upper, temporal and lower statistically significantly decreased in the control group, while remaining unchanged in the observation group (р < 0.05). Spatial contrast sensitivity (SCS) after 1 year of use Retinorm remained at the same level in the control group, while there was a statistically significant increase in spatial contrast sensitivity in the main group, especially at high spatial frequencies is observed (р < 0.05). Conclusion. The results of the study indicate a positive effect of Retinorm used for 1 year. It was reflected in the improvement visual acuity in the distance, improvement of spatial contrast sensitivity, especially at high spatial frequencies, and the preservation of structural retinal indices both in the foveal zone and peripapillary. |
Author | Dorofeev, D. A. |
Author_xml | – sequence: 1 givenname: D. A. surname: Dorofeev fullname: Dorofeev, D. A. organization: Public Clinical Hospital of Chelyabinsk No. 3 |
BookMark | eNo9kd1q3DAQRkVJods076A8gNKRZMny5bL5aWBLQkmvxVgeuQqOtNhekkAePt5sydU3zAwHZs53dpJLJsbOJVxIB-B-SietMNAYoUA6oYXWjdBV_YWtlAEQ4Cpzwlafa9_Y2TQ9AoA0UkplV-xtu58pZbEpecaUU-75Os-pvKQO8zzxlPk9zokO9XOa__H7MT3h-MrvdpTFOvcD8ZsB96E8Icfc8ctl9vC6I14iX_ck_tCAM3X8N4b9gCO_pJ4yjQuz5B_sa8RhorP_ecr-Xl89bH6J7d3N7Wa9FUE1uhYanJURq7aq2ggqxsaZ4Aw4ZZcIulFta0FqV2tbyca2MlqDeokgsQatT9ntkdsVfPS74wW-YPIfjTL2Hsc5hYF8Fx1hS5VtO6gcRBdUWGi1IgQTalxYzZEVxjJNI8VPngT_YcUf3u0P7_YHK177xYpfrOh3jpiCTA |
CitedBy_id | crossref_primary_10_29413_ABS_2022_7_1_12 crossref_primary_10_18008_1816_5095_2022_4_885_892 crossref_primary_10_18008_1816_5095_2020_4_804_810 |
Cites_doi | 10.21689/2311-7729-2017-17-3-155-160 10.17816/KMJ1804 10.1001/archopht.119.10.1439 10.1001/archopht.121.12.1728 10.1001/jama.2013.4997 10.21689/2311-7729-2017-17-4-195-200 10.21689/2311-7729-2017-17-4-235-238 10.1001/archopht.1995.01100070092031 10.1016/S0181-5512(08)73684-2 10.1006/mvre.1993.1007 |
ContentType | Journal Article |
DBID | AAYXX CITATION DOA |
DOI | 10.18008/1816-5095-2018-3-339-347 |
DatabaseName | CrossRef Directory of Open Access Journals |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2500-0845 |
EndPage | 347 |
ExternalDocumentID | oai_doaj_org_article_df8eabe46bd0480f8c2cf6572ea05c7a 10_18008_1816_5095_2018_3_339_347 |
GroupedDBID | 5VS AAYXX ABDBF ALMA_UNASSIGNED_HOLDINGS CITATION ESX GROUPED_DOAJ KQ8 |
ID | FETCH-LOGICAL-c2937-30861fa4b44bf02ff985c850826c85c392bb601387364196b1f65a3b1fc1a7033 |
IEDL.DBID | DOA |
ISSN | 1816-5095 |
IngestDate | Mon Oct 21 19:39:52 EDT 2024 Fri Aug 23 02:26:06 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English Russian |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2937-30861fa4b44bf02ff985c850826c85c392bb601387364196b1f65a3b1fc1a7033 |
OpenAccessLink | https://doaj.org/article/df8eabe46bd0480f8c2cf6572ea05c7a |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_df8eabe46bd0480f8c2cf6572ea05c7a crossref_primary_10_18008_1816_5095_2018_3_339_347 |
PublicationCentury | 2000 |
PublicationDate | 2018-10-05 |
PublicationDateYYYYMMDD | 2018-10-05 |
PublicationDate_xml | – month: 10 year: 2018 text: 2018-10-05 day: 05 |
PublicationDecade | 2010 |
PublicationTitle | Oftalmologii͡a |
PublicationYear | 2018 |
Publisher | Ophthalmology Publishing Group |
Publisher_xml | – name: Ophthalmology Publishing Group |
References | ref13 ref12 ref15 ref14 ref30 ref11 ref10 ref2 ref1 ref17 ref16 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 |
References_xml | – ident: ref30 doi: 10.21689/2311-7729-2017-17-3-155-160 – ident: ref3 – ident: ref5 – ident: ref20 – ident: ref22 doi: 10.17816/KMJ1804 – ident: ref29 – ident: ref24 doi: 10.1001/archopht.119.10.1439 – ident: ref7 doi: 10.1001/archopht.121.12.1728 – ident: ref9 – ident: ref19 – ident: ref25 doi: 10.1001/jama.2013.4997 – ident: ref11 – ident: ref17 – ident: ref15 – ident: ref13 – ident: ref4 – ident: ref2 – ident: ref16 doi: 10.21689/2311-7729-2017-17-4-195-200 – ident: ref28 – ident: ref26 doi: 10.21689/2311-7729-2017-17-4-235-238 – ident: ref21 – ident: ref23 – ident: ref8 – ident: ref18 – ident: ref6 doi: 10.1001/archopht.1995.01100070092031 – ident: ref10 – ident: ref12 – ident: ref1 doi: 10.1016/S0181-5512(08)73684-2 – ident: ref14 – ident: ref27 doi: 10.1006/mvre.1993.1007 |
SSID | ssj0001511126 |
Score | 2.106018 |
Snippet | Objective.
To assess the dynamics of structural-functional markers in patients with combined pathology: primary open-angle glaucoma (POAG) and age-related... Objective. To assess the dynamics of structural-functional markers in patients with combined pathology: primary open-angle glaucoma (POAG) and age-related... |
SourceID | doaj crossref |
SourceType | Open Website Aggregation Database |
StartPage | 339 |
SubjectTerms | age-related macular degeneration etdrs glaucoma lutein-containing preparations nutraceuticals spatial contrast sensitivity |
Title | Lutein-Containing Antioxidants in Patients with Primary Open-Angle Glaucoma and Dry Type of Age-Related Macular Degeneration |
URI | https://doaj.org/article/df8eabe46bd0480f8c2cf6572ea05c7a |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NS8MwFA-yw_AifuL8IoLXsLZps_RYnTrEyQ4Odgv56hiMTuYKHvzjfa-pYzcvngopLekvL8nvNb_3HiF3QDm8iyzMNGAjLHU-YcZZwWJvDNBd7RKDAc7jNzGapi-zbLZT6gs1YSE9cACu70rptfGpMA7Dn0tpE1uKbJB4HWV2EKhRlO84UyE-OMbYGPS2ZCwY7IpZl9ziCgFdkv1tIxhJjPIAznPGscTKzua0k8O_2WyeDslByxJpEXp3RPbW9THpjttz8BPy_VpjlUqGuaVCiQdaoGzxa-FQ10IXFZ2EhKmfFP-00klIKkFRP8KKar709HmpazA3TXXl6BDuoUtKVyUt5p41Gjnv6Fg3OlU69PMmPzUO4ymZPj2-P4xYW0eBWdjMYQ0BtyUudWrS1JRRUpa5zKwEZpYIuFhgSDAueGI54CKFGWliAFhzuNhYw4rAz0inWlX-nFBwxwwgH0fe8lS7XGpuuQAWAYMkpMt7JPkFUH2EL1PoZiDqClFXiLpC1BVXgLoC1HvkHqHePoAZr5sGsAPV2oH6yw4u_uMll2S_MYhGIHBFOpt17a-BdGzMTWNfP-Y70XE |
link.rule.ids | 315,783,787,867,2109,27938,27939 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lutein-Containing+Antioxidants+in+Patients+with+Primary+Open-Angle+Glaucoma+and+Dry+Type+of+Age-Related+Macular+Degeneration&rft.jtitle=Oftalmologii%CD%A1a&rft.au=D.+A.+Dorofeev&rft.date=2018-10-05&rft.pub=Ophthalmology+Publishing+Group&rft.issn=1816-5095&rft.eissn=2500-0845&rft.volume=15&rft.issue=3&rft.spage=339&rft.epage=347&rft_id=info:doi/10.18008%2F1816-5095-2018-3-339-347&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_df8eabe46bd0480f8c2cf6572ea05c7a |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1816-5095&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1816-5095&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1816-5095&client=summon |